Comparing Approaches to Measure Frailty in Medicare Data: Deficit-Accumulation Frailty Index Versus Phenotypic Frailty.
作者信息
Kim Dae Hyun, Schneeweiss Sebastian, Glynn Robert J
机构信息
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
出版信息
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):989-990. doi: 10.1093/gerona/gly054.
Abstract
摘要
相似文献
1
Comparing Approaches to Measure Frailty in Medicare Data: Deficit-Accumulation Frailty Index Versus Phenotypic Frailty.比较医疗保险数据中测量衰弱的方法：累积缺陷衰弱指数与表型衰弱
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):989-990. doi: 10.1093/gerona/gly054.
2
Operationalizing Frailty Using the Frailty Phenotype and Deficit Accumulation Approaches.运用衰弱表型和累积缺陷方法实现衰弱的可操作性评估
Interdiscip Top Gerontol Geriatr. 2015;41:66-73. doi: 10.1159/000381164. Epub 2015 Jul 17.
3
Claims-Based Frailty Index Options.基于索赔的衰弱指数选项。
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):988. doi: 10.1093/gerona/gly055.
4
Frailty, Equity, and Medicare Costs.虚弱、公平与医疗保险费用。
Ann Intern Med. 2020 Apr 21;172(8):562-563. doi: 10.7326/M20-0873. Epub 2020 Apr 7.
5
Comparison and Clinical Applications of the Frailty Phenotype and Frailty Index Approaches.衰弱表型与衰弱指数方法的比较及临床应用
Interdiscip Top Gerontol Geriatr. 2015;41:74-84. doi: 10.1159/000381166. Epub 2015 Jul 17.
6
External validation of the claims-based frailty index in the national health and aging trends study cohort.基于索赔的衰弱指数在国家健康与老龄化趋势研究队列中的外部验证
Am J Epidemiol. 2017 Sep 15;186(6):745-747. doi: 10.1093/aje/kwx257.
7
Function and Frailty: Value Added in Medicare.功能与衰弱：医疗保险中的附加价值。
Ann Intern Med. 2023 Apr;176(4):578-579. doi: 10.7326/M23-0563. Epub 2023 Apr 4.
8
Comparing clinician descriptions of frailty and geriatric syndromes using electronic health records: a retrospective cohort study.使用电子健康记录比较临床医生对虚弱和老年综合征的描述：一项回顾性队列研究。
BMC Geriatr. 2017 Oct 25;17(1):248. doi: 10.1186/s12877-017-0645-7.
9
Frailty Before Critical Illness and Mortality for Elderly Medicare Beneficiaries.老年医疗保险受益人的危重病前虚弱状态与死亡率
J Am Geriatr Soc. 2015 Jun;63(6):1121-8. doi: 10.1111/jgs.13436.
10
Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index.在 Medicare 数据中测量虚弱程度：基于索赔的虚弱指数的开发和验证。
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):980-987. doi: 10.1093/gerona/glx229.
引用本文的文献
1
Trends in post-acute care and outcomes for Medicare beneficiaries hospitalized for heart failure between 2008 and 2015.2008 年至 2015 年期间，因心力衰竭住院的 Medicare 受益人的急性后期护理和结局趋势。
J Am Geriatr Soc. 2023 Mar;71(3):730-741. doi: 10.1111/jgs.18109. Epub 2022 Nov 1.
2
Heath status, frailty, and multimorbidity in patients with emergency general surgery conditions.急症普通外科患者的健康状况、脆弱性和多种合并症。
Surgery. 2022 Jul;172(1):446-452. doi: 10.1016/j.surg.2022.02.011. Epub 2022 Apr 6.
3
Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes.钠-葡萄糖共转运蛋白 2 抑制剂与老年 2 型糖尿病患者骨折风险的关联。
JAMA Netw Open. 2021 Oct 1;4(10):e2130762. doi: 10.1001/jamanetworkopen.2021.30762.
4
A roadmap to build a phenotypic metric of ageing: insights from the Baltimore Longitudinal Study of Aging.建立衰老表型指标的路线图：来自巴尔的摩纵向衰老研究的见解。
J Intern Med. 2020 Apr;287(4):373-394. doi: 10.1111/joim.13024. Epub 2020 Feb 27.
5
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.恩格列净疗效与安全性比较（EMPRISE）研究项目：恩格列净在常规临床治疗中评估的设计与暴露积累情况
Endocrinol Diabetes Metab. 2019 Nov 26;3(1):e00103. doi: 10.1002/edm2.103. eCollection 2020 Jan.
6
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.使用真实世界数据预测正在进行的 IV 期心血管结局试验的结果：利拉利汀与格列美脲的心血管安全性。
Diabetes Care. 2019 Dec;42(12):2204-2210. doi: 10.2337/dc19-0069. Epub 2019 Jun 25.
7
Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study.基于索赔的衰弱指数对健康与退休研究中身体表现和不良健康结果的验证。
J Gerontol A Biol Sci Med Sci. 2019 Jul 12;74(8):1271-1276. doi: 10.1093/gerona/gly197.
本文引用的文献
1
Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index.在 Medicare 数据中测量虚弱程度：基于索赔的虚弱指数的开发和验证。
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):980-987. doi: 10.1093/gerona/glx229.
2
Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype.基于既定衰弱表型的基于索赔的衰弱指标的开发。
Med Care. 2017 Jul;55(7):716-722. doi: 10.1097/MLR.0000000000000729.
3
Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations.利用索赔数据测量老年人死亡率药物流行病学研究中的衰弱：证据与建议。
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):891-901. doi: 10.1002/pds.3674. Epub 2014 Jun 24.
Zotero 插件